Pharmacogenetics of psoriasis:HLA-Cw6but notLCE3B/3Cdeletion norTNFAIP3polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab

乌斯特基努马 银屑病 医学 阿维A 遗传倾向 银屑病面积及严重程度指数 药物遗传学 免疫学 内科学 阿达木单抗 疾病 基因型 遗传学 生物 基因
作者
Marina Talamonti,E. Botti,Marco Galluzzo,Miriam Teoli,Giulia Spallone,Mauro Bavetta,Sergio Chimenti,Antonio Costanzo
出处
期刊:British Journal of Dermatology [Oxford University Press]
卷期号:169 (2): 458-463 被引量:145
标识
DOI:10.1111/bjd.12331
摘要

BACKGROUND: Our understanding of the genetic basis of predisposition to psoriasis is increasing exponentially due to the progress of genetic studies. However, so far little is known about genetic predisposition in relation to the response to psoriasis treatments. Recent data identified genetic predictors for the clinical outcome of conventional treatments such as methotrexate, acitretin and vitamin D derivatives, but few studies are available on genetic predictors of response to biologics. We hypothesized that genetic variations associated with increased risk of developing psoriasis may also act as predictors for the outcome of biologic therapy. OBJECTIVES: The aim of our study was to analyse the presence of three different psoriasis susceptibility genetic variations (HLA-Cw6; TNFAIP3 rs610604 polymorphism; LCE3B/3C gene deletions) in a cohort of patients affected by moderate to severe psoriasis under ustekinumab treatment. Our primary endpoint was to evaluate the association between Psoriasis Area and Severity Index (PASI) 75 response at week 12 and HLA-Cw6 status. METHODS: Fifty-one patients were genotyped by standard methods and psoriasis severity (PASI score) was evaluated at day 0 and after 4, 12, 24 and 40 weeks of treatment. RESULTS: We observed increased response to ustekinumab in Cw6-positive (Cw6POS) patients [PASI 75 at week 12: 96·4% in Cw6POS vs. 65·2% in Cw6-negative (Cw6NEG) patients; P = 0·008]. In addition, we show that HLA-Cw6POS patients responded faster to ustekinumab, 89·3% of them reaching PASI 50 at week 4, after a single injection (vs. 60·9% of HLA-Cw6NEG patients). The superior response of HLA-Cw6POS patients was maintained throughout the study period, reaching the highest statistical significance for PASI 75 at week 28 (96·35% Cw6POS vs. 72·7% Cw6NEG; odds ratio 9·8). Analysis of TNFAIP3 rs610604 polymorphism and LCE3B/3C gene deletions did not show any significant association with response to ustekinumab. CONCLUSIONS: Our observations underline the role of HLA-Cw6 not only as a psoriasis susceptibility gene, but also as a pharmacogenetic marker of response to ustekinumab in psoriasis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI6.4的应助被haoyun采纳,获得10
刚刚
一生所爱完成签到,获得积分10
刚刚
刚刚
饺子完成签到,获得积分10
1秒前
脑洞疼的应助被Wiesen采纳,获得10
1秒前
molihuakai的应助被ZsJJkk采纳,获得30
1秒前
1秒前
1秒前
jiangsuway发布了新的文献求助10
2秒前
喝口可乐的应助被大意的元珊采纳,获得10
2秒前
无敌的忧伤完成签到,获得积分10
2秒前
陶炳君完成签到 ,获得积分10
2秒前
3秒前
重要莹发布了新的文献求助10
3秒前
酷酷的浩天完成签到 ,获得积分10
3秒前
李爱国的应助被迷人葶采纳,获得10
3秒前
3秒前
123完成签到,获得积分10
3秒前
赵永刚发布了新的文献求助10
3秒前
小北发布了新的文献求助10
3秒前
4秒前
4秒前
荔枝完成签到,获得积分10
4秒前
七十三度发布了新的文献求助10
5秒前
5秒前
Cecilia完成签到,获得积分10
5秒前
辰月三三完成签到,获得积分10
5秒前
6秒前
mkl发布了新的文献求助10
6秒前
好好完成签到,获得积分10
6秒前
6秒前
6秒前
zhang完成签到,获得积分10
6秒前
猫猫头完成签到,获得积分10
6秒前
Ava的应助被微血管采纳,获得10
6秒前
冷酷保温杯完成签到,获得积分10
6秒前
朴素幼晴完成签到,获得积分10
7秒前
浮世等清欢完成签到,获得积分10
7秒前
今日有雪完成签到 ,获得积分10
7秒前
田文月完成签到,获得积分10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180531
求助须知:如何正确求助?哪些是违规求助? 9570507
关于积分的说明 21812974
捐赠科研通 7776619
什么是DOI,文献DOI怎么找? 3433286
关于科研通互助平台的介绍 2557539
邀请新用户注册赠送积分活动 2479185